two things are clear to me. First, posters have no idea what is meant by exponential growth. Second, AHZ have found it a lot tougher to penetrate their market with Cardiocel than they had imagined. AHZ dare not present raw sales figures because of the consequences in the minds of investors - the only thing that's clear is their spending is out of all proportion to revenue - can't talk about earnings, they have none.... not a good look overall and the market knows it.
AHZ Price at posting:
7.6¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)